| 发明名称 |
USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER |
| 摘要 |
Use of the non-peptide NK1 receptor antagonist, preferably Aprepitant, for the treatment of cancer in predetermined doses. The present invention also describes pharmaceutical compositions comprising said agents, alone or in combination with at least one other active principle, for the treatment of cancer |
| 申请公布号 |
US2016317544(A1) |
申请公布日期 |
2016.11.03 |
| 申请号 |
US201415107623 |
申请日期 |
2014.12.26 |
| 申请人 |
SERVICIO ANDALUZ DE SALUD |
发明人 |
SALINAS MARTIN Manuel Vicente |
| 分类号 |
A61K31/5377;A61K33/24 |
主分类号 |
A61K31/5377 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating cancer in a mammal, said method comprising administering a composition comprising a non-peptide NK1 receptor antagonist at doses between 5 and 120 mg/kg of weight per day. |
| 地址 |
Sevilla ES |
